Procalcitonin: What should be its role in the clinical management of febrile patients admitted to the hospital? [3]

Clinical Infectious Diseases

Volumn 36, Issue 6, 2003, Pages 824-825

  Van Dissel, Jaap T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

ANTIBIOTIC THERAPY; BACTEREMIA; BLOOD CULTURE; DISEASE MARKER; ENDOTOXEMIA; FEVER; HOSPITAL PATIENT; HUMAN; LETTER; PRIORITY JOURNAL;

BACTEREMIA; BIOLOGICAL MARKERS; CALCITONIN; FEVER; HOSPITALIZATION; HUMANS; PROGNOSIS; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY;

EID: 0037444019     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/368087     Document Type: Letter

References (5)

1. Chirouze C, Schuhmacher H, Rabaud C, et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002; 35:156-61.
2. van Dissel JT, van Langevelde P, Westendorp RGJ, Kwappenberg K, Frolich M. An anti-inflammatory cytokine profile is associated with mortality in febrile patients admitted to the hospital. Lancet 1998; 351:950-3.
3. van Langevelde P, Joop K, van Loon J, et al. Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000; 31:1343-8.
4. Bossink AWJ, Groeneveld J, Koffeman GI, Becker A. Prediction of shock in febrile patients with clinical infection. Crit Care Med 2001; 29:25-31.
5. Surpin E, Camus C, Gacouin A, et al. Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med 2000; 26:1170-1.